Medical specialists from India tagged as investigators in clinical trials studying Glomerulonephritis
Total 5 results
-
Gopalakrishnan NatarajanSeen in:
- Tamil Nadu, Chen, Madras Medical College
Trials:- NCT05434325 (Principal Investigator)
Conditions: -
Manisha SahaySeen in:
- Andhra Pradesh, Hyderabad, Osmania General Hospital
- Telangana, Hyderabad, Osmania General Hospital
Trials:- NCT04573478 (Principal Investigator)
- NCT05434325 (Principal Investigator)
Conditions: -
Raja RamachandranSeen in:
- Punjab, Chandigarh, Post Graduate Institue of Medical Education and Reasearch
Trials:- NCT05434325 (Principal Investigator)
Conditions: -
Sreebhushan Raju DevarajuSeen in:
- Andhra Pradesh, Hyderabad, Nizams Institute of Medical Sciences
Trials:- NCT05434325 (Principal Investigator)
Conditions: -
Sreelatha MelemadathilSeen in:
- Kerala, Kozhikode, Calicut Medical College
- Kerala, Kozhikode, Government Medical College
Trials:- NCT04573478 (Principal Investigator)
- NCT05434325 (Principal Investigator)
Conditions:
Clinical Trials on Glomerulonephritis
-
Celldex TherapeuticsTerminatedC3 Glomerulonephritis | Dense Deposit Disease | Membranoproliferative Glomerulonephritis Type IIUnited States
-
Alexion PharmaceuticalsAchillion, a wholly owned subsidiary of AlexionCompletedC3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Mediated Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis Types I, II, and IIINetherlands, Australia, Belgium
-
Mario Negri Institute for Pharmacological ResearchAlexion PharmaceuticalsCompletedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisItaly
-
University Magna GraeciaCompletedIGA GlomerulonephritisItaly
-
Assiut UniversityUnknownMembranoproliferative Glomerulonephritis
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Spain, France, Germany, United Kingdom, Netherlands, Brazil, Israel, Japan, Australia, Austria, Italy, Switzerland, Korea, Republic of, Czechia, Belgium, Argentina, Canada, Poland
-
Apellis Pharmaceuticals, Inc.Active, not recruitingC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States, Australia, Brazil, Czechia, France, Italy, Korea, Republic of, Netherlands, Spain, Switzerland, United Kingdom
-
Apellis Pharmaceuticals, Inc.AvailableC3G | IC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Complement 3 Glomerulopathy | Complement 3 Glomerulopathy (C3G) | Complement 3 Glomerulonephritis | Dense Deposit Disease | DDD | Membranoproliferative Glomerulonephritis | Membranoproliferative Glomerulonephritis (MPGN) | Immune Complex Membranoproliferative...United States
-
AlexionTerminatedIC-MPGN | C3 Glomerulopathy | C3 Glomerulonephritis | Dense Deposit Disease | Immune Complex Membranoproliferative GlomerulonephritisUnited States, Australia, Belgium, Italy, Netherlands
-
Mayo ClinicCompletedGlomerulonephritis, MembranoproliferativeUnited States